RT Journal Article
SR Electronic
T1 Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.16.20213298
DO 10.1101/2020.10.16.20213298
A1 Russell Viner
A1 Joseph Ward
A1 Lee Hudson
A1 Melissa Ashe
A1 Sanjay Patel
A1 Dougal Hargreaves
A1 Elizabeth Whittaker
YR 2020
UL http://medrxiv.org/content/early/2020/10/18/2020.10.16.20213298.abstract
AB Objective To undertake a systematic review of reviews of the prevalence of symptoms and signs of COVID-19 in those aged under 20 years?Design Narrative systematic review of reviews. PubMed, medRxiv, Europe PMC and COVID-19 Living Evidence Database were searched on 9 October 2020.Setting All settings, including hospitalised and community settings.Patients CYP under age 20 years with laboratory-proven COVID-19.Study review, data extraction and quality Potentially eligible articles were reviewed on title and abstract by one reviewer. Quality was assessed using the modified AMSTARS criteria and data were extracted from included studies by two reviewers.Main outcome measures Prevalence of symptoms and signs of COVID-19Results 1325 studies were identified and 18 reviews were included. Eight were high quality, 7 medium and 3 low quality. All reviews were dominated by studies of hospitalised children. The proportion who were asymptomatic ranged from 14.6 to 42%. Fever and cough were the commonest symptoms; proportions with fever ranged from 46 to 64.2% and with cough from 32 to 55.9%. All other symptoms or signs including rhinorrhoea, sore throat, headache, fatigue/myalgia and gastrointestinal symptoms including diarrhoea and vomiting are infrequent, occurring in less than 10-20%.Conclusions Fever and cough are the most common symptoms in CYP with COVID-19, with other symptoms infrequent. Further research on symptoms in community samples are needed to inform pragmatic identification and testing programmes for CYP.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNil funding obtained for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not required for these secondary analyses of published data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll included articles in this systematic review are available open-access on-line.